Rapid <i>in vitro</i> assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4 <sup>+</sup> T cell interleukin-2 secretion
Yoshiyuki Arata(Chugai Pharma (United States)), Chiyomi Kubo(Chugai Pharma (United States))
Cited by 8
Related Papers
No related papers found
Powered by citation graph analysis